Diabetes Drug Discovery

3 - 4 November 2011
Conference
Boston, MA, US

This is the fourth annual event on Diabetes Drug Discovery and is part of the Discovery on Target conference that runs from 2–4 November. Podium presentations, expert panel sessions and roundtable breakout discussions will address topics such as: clinical progress of SGLT2 inhibitors and other oral anti-diabetic drug candidates, effectiveness of targeting glucose lowering rather than insulin sensitivity or production and new compounds in preclinical development

Organiser: Cambridge Healthtech Institute